3816 results for «222»
3816 results
Mitral innovations
29 Nov 2022 – From PCR London Valves 2022
Discover some innovative mitral interventions with this selection of cases: transcatheter mitral edge-to-edge repair under intracardiac echocardiography only, MitraClip procedure and other structural heart interventions in augmented reality, 3D simulation to guide TMVR in a patient with prior rheumatic heart disease and aortic dissection, and more!
TAVI complications: Session 4
29 Nov 2022 – From PCR London Valves 2022
With this selection of challenging cases, discover how to face various TAVI complications, such as: annular perforation, lost wire, aortoiliac rupture, bilateral coronary ostial occlusion, and much more!
Rapid-fire abstracts: Session 10
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: trends in utilisation of percutaneous tricuspid valve vegetation debulking in endocarditis 2017-19, association of TRI-SCORE with clinical outcomes after transcatheter tricuspid valve repair, transcatheter edge-to-edge repair vs. percutaneous annuloplasty for tricuspid regurgitation, and more!
Rapid-fire clinical cases: Session 5
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of cases submitted at PCR LV 2022 in this session: subacute thrombosis of a balloon-expandable aortic bioprosthesis, left axillary access for TAVI in a patient with two IMA grafts and a left side implanted pacemaker, avoiding paravalvular leak using computer simulation in bicuspid TAVI,...
Rapid-fire abstracts: Session 11
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: the impact of cerebral embolic protection devices on acute ischaemic stroke complicating TAVI, TTVR clinical results prediction based on surgical risk scores, effects of tricuspid transcatheter edge-to-edge repair on tricuspid annular diameter, and much more!
Rapid-fire clinical cases: Session 6
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: valve-in-valve implant in a dysfunctional tricuspid bioprosthesis, first patient in TRICURE FIH trial, challenging percutaneous closure of prosthetic paravalvular leaks, and more!
Imaging in TAVI with challenging anatomy
14 Dec 2022 – From GulfPCR-GIM 2022
Through the 3 cases presented in this GulfPCR-GIM 2022 session and the highly informative discussion among your peers, learn how to use TAVI with difficult anatomies such as bicuspid aortic valves by relying on imaging.
Bifurcation lesion
14 Dec 2022 – From GulfPCR-GIM 2022
Among the 3 bifurcation lesion cases presented in this GulfPCR-GIM 2022 session, find out how to deliver a trapped guidewire, how to manage a live angioplasty that turned out to be a nightmare, and how to deal with a multivessel intervention with left main bifurcation and...
Trial review 2022: my five most impactful clinical trials
14 Dec 2022 – From GulfPCR-GIM 2022
In this session of GulfPCR-GIM 2022, Andreas Baumbach has the honour of presenting the 5 clinical trials that he considers to be the most important of the year 2022. His choice is between trials that could change our practice, those that confirm it, certain guidelines, or...
Clinical outcomes of calcified nodules detected by optical coherence tomography: a sub-analysis of the CLIMA study
10 Sep 2020
The goal of the present post hoc analysis of the CLIMA registry was to establish the relationship between calcified nodules (CNs) with (CND) or without (CNWD) disruption of the superficial intimal fibrous layer and one-year occurrence of target lesion myocardial infarction (MI) and/or cardiac death.
Authors :
PCR and EAPCI Statement Percutaneous edge-to-edge repair in patients with heart failure and secondary mitral regurgitation
21 May 2019
Paris, France, 21 May 2019. Heart failure is a common cardiovascular disorder with ominous prognosis despite significant therapeutic advances. Mitral regurgitation (MR, leaking of the mitral valve within the heart) affects at least 50% of patients with heart failure and is independently associated with worse prognosis....
Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial
31 Oct 2025
Nicola Ryan provides her take on the PROMISE trial presented by Rocco Antonio Montone at TCT 2025, in San Francisco.
Author
Impella percutaneous ventricular assist device malrotation in social media: a call to action
20 Apr 2023
The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications.
Author
Author
Author
Author
Author
The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction
18 Nov 2024
Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.
Author
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
01 Sep 2024
Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.
Author
Author
Author
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons
23 Jan 2025
Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.
Author
Author
